Mice Showed Hyperactivity and Paw Tremors During THC Withdrawal

Mice chronically treated with THC and then given a CB1 blocker showed hyperlocomotion (4x normal activity) and paw tremors as quantifiable withdrawal signs.

Huang, Peng et al.·Neuroscience letters·2009·Preliminary EvidenceAnimal StudyAnimal Study
RTHC-00359Animal StudyPreliminary Evidence2009RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

C57BL/6 mice received THC (25 mg/kg) or vehicle twice daily for 4.5 days. The CB1 receptor antagonist SR141716 (rimonabant) was then administered to precipitate withdrawal.

THC-treated mice showed dramatically increased locomotor activity: total activity was 4.1 times, ambulatory activity 3.3 times, and stereotypic activity 3.8 times that of vehicle-treated controls.

Paw tremors were even more dramatic: THC-treated mice showed 111 paw tremors in 45 minutes versus only 1.1 in controls.

Interestingly, scratching behavior showed the opposite pattern: vehicle-treated mice scratched 182 times versus only 17 times in THC-treated mice.

This was the first study to demonstrate hyperlocomotion as an explicit THC withdrawal sign in mice.

Key Numbers

THC dose: 25 mg/kg twice daily for 4.5 days. Total locomotor activity: 4.1x control. Ambulatory activity: 3.3x. Stereotypic activity: 3.8x. Paw tremors: 111 vs 1.1 in 45 minutes. Scratching: 17 vs 182 (reversed direction).

How They Did This

C57BL/6 mice received twice-daily subcutaneous THC (25 mg/kg) or vehicle for 4.5 days. Four hours after the last dose, SR141716 (15 mg/kg) was administered to precipitate withdrawal. Locomotor activity and specific behaviors were recorded for 2 hours.

Why This Research Matters

Establishing reliable, quantifiable withdrawal signs in animal models is essential for studying the mechanisms of cannabis dependence and developing potential treatments.

The Bigger Picture

Cannabis withdrawal has been increasingly recognized as clinically significant in humans. Animal models with clear, measurable withdrawal signs allow researchers to investigate the neurobiology of dependence and test potential pharmacological interventions.

What This Study Doesn't Tell Us

Animal withdrawal was precipitated by an antagonist rather than occurring naturally through abstinence. THC doses were much higher relative to body weight than typical human use. Mouse behavior may not directly model human withdrawal experiences.

Questions This Raises

  • ?Do these same withdrawal mechanisms operate in humans?
  • ?Would the hyperlocomotion seen in mice correspond to the restlessness reported by humans during cannabis withdrawal?
  • ?Can these quantifiable signs be used to screen potential withdrawal treatments?

Trust & Context

Key Stat:
4.1x locomotor activity and 100-fold increase in paw tremors during THC withdrawal
Evidence Grade:
Preclinical animal study using precipitated (not spontaneous) withdrawal in a single mouse strain.
Study Age:
Published in 2009. Cannabis withdrawal has since been formally recognized in diagnostic manuals, and animal models continue to be refined.
Original Title:
Hyperlocomotion and paw tremors are two highly quantifiable signs of SR141716-precipitated withdrawal from delta9-tetrahydrocannabinol in C57BL/6 mice.
Published In:
Neuroscience letters, 465(1), 66-70 (2009)
Database ID:
RTHC-00359

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

What does precipitated withdrawal mean?

Instead of waiting for THC to leave the system naturally, researchers administered a CB1 receptor blocker (rimonabant) to immediately reverse THC effects, triggering rapid withdrawal. This produces more consistent and dramatic withdrawal signs than natural abstinence.

Do humans experience similar withdrawal symptoms?

Human cannabis withdrawal includes irritability, sleep difficulties, restlessness, and decreased appetite. The hyperlocomotion in mice may correspond to the restlessness and agitation humans report, though direct comparisons between mouse and human behavior require caution.

Read More on RethinkTHC

Cite This Study

RTHC-00359·https://rethinkthc.com/research/RTHC-00359

APA

Huang, Peng; Liu-Chen, Lee-Yuan; Unterwald, Ellen M; Cowan, Alan. (2009). Hyperlocomotion and paw tremors are two highly quantifiable signs of SR141716-precipitated withdrawal from delta9-tetrahydrocannabinol in C57BL/6 mice.. Neuroscience letters, 465(1), 66-70. https://doi.org/10.1016/j.neulet.2009.08.073

MLA

Huang, Peng, et al. "Hyperlocomotion and paw tremors are two highly quantifiable signs of SR141716-precipitated withdrawal from delta9-tetrahydrocannabinol in C57BL/6 mice.." Neuroscience letters, 2009. https://doi.org/10.1016/j.neulet.2009.08.073

RethinkTHC

RethinkTHC Research Database. "Hyperlocomotion and paw tremors are two highly quantifiable ..." RTHC-00359. Retrieved from https://rethinkthc.com/research/huang-2009-hyperlocomotion-and-paw-tremors

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.